EN DE
Watch Burcon NutraScience Corporation for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Burcon NutraScience Corporation (BU) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Burcon NutraScience Corporation stock C$0.62, price C$0.95, that is 34.6% below the price, quality 20 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive CA · ISIN CA1208311029

BN Burcon NutraScience Corporation logo Thin data Nov 10, 2026

Burcon NutraScience Corporation

BU · TO
Expensive, weak quality

Our calculation puts a fair price 35% below what the stock costs today.

Mixed Growth (revenue 5y +54.3 %/yr in CAD)
Negative equity (buybacks among others)
Fair value C$0.6216 · Overvalued
Quality 20/100
Negative free cash flow
Trails peers (1/5)
Narrow moat 30/100 · thin data
Thin data
Estimate
Watch Burcon NutraScience Corporation for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

C$53.43 C$0.9000 Fair Value C$0.6216 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range C$0.9000 – C$53.43 · fair‑value band C$0.4662 – C$0.7770 · the C$0.9500 price screens above the C$0.6216 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Burcon NutraScience in your weekly email

Every Wednesday you see whether Burcon NutraScience is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Burcon NutraScience Corporation, together with its subsidiaries, provides plant-based proteins for the food and beverage industry in Canada.

Show moreShow less

The company offers peas, which includes Peazazz, a pea protein for use in dairy alternatives; and canola protein, which comprises meat alternatives, egg alternatives, non-dairy frozen desserts, ready-to-mix beverages, whipped toppings and nutrition bars, and other concentrated protein supplements.

It also provides soy that includes soy protein, a protein replacement for dairy proteins in food or in products, such as protein shakes, power bars, soups and sauces, meat alternatives, and breads and baked goods; and CLARISOY for sports nutrition beverages, citrus-based drinks, fruit-flavoured beverages, lemonades, powdered beverage mixes, and in various non-beverage plant-based applications.

In addition, the company offers Solatein, a sunflower protein isolate; FavaPro fava protein and other plant proteins; hemp protein isolate; flax protein; and protein blends. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999.

Burcon NutraScience Corporation was incorporated in 1998 and is headquartered in Vancouver, Canada.

Stock analysis

Burcon NutraScience Corporation (BU) currently trades at C$0.9500, while our estimate is C$0.6216, 35% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: C$0.4662 (bear) to C$0.7770 (bull), the price of C$0.9500 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 20/100 (below-average quality), in the Consumer Defensive sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Burcon NutraScience Corporation reported revenue of C$2.3M in FY2026 versus C$171K in FY2022, a compound +90.6%/yr. Reported net income was −C$14.3M in FY2026.

Key figures

Market cap C$12.1M (≈ $8.5M) Micro · P/S ratio 3.81 · EPS (TTM) C$−1.15 · Return on equity −2,489% · Return on assets (EBIT) −46.8% (5-year average) · Operating margin −246% · Revenue (TTM) C$3.2M · Revenue growth (YoY) +273%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 30 out of 100 (low confidence).

What moves the price

The share trades about 62% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 2% fair-value upside, at −35%, BU screens richer than that median.

Fair Value

Bear C$0.4662 Fair Value C$0.6216 Bull C$0.7770
Price C$0.9500 · Downside -34.6%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 20/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 59
Are margins and returns getting better?
Cashflow 3
Do the profits arrive as real cash?
Financial strength 5
Debt, balance sheet and risk of trouble
Investment 33
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 50
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 30/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+493.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+83.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+54.3%
Start year 2021 (pandemic). Over 10 years: +35.8% a year
Revenue growth 26 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+75.6%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1,776.7% (2021) → −506.1% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

BU screens overvalued: fair value 35% below the price. Compare with Nestlé S.A →

Compare Burcon NutraScience Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 660 stocks

Beats the industry median on 1/5 measures
Overall it trails its industry peers.
Valuation
Quality Score 20 · Bottom 25%
Fair Value upside −34.6% · Bottom 25%
Profitability
Return on equity (12 months) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −62.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 273.0% · Top 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Packaged Foods median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months) 3.77× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 34
FUTURE (revenue growth)100 · sector 25
PAST (return on equity)0 · sector 30
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 55

VALUE 0: the price sits above our fair-value range.

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wilmar International Limited F34 2.95 SGD 4.93 SGD +67% vs BU
Inner Mongolia Yili Industrial Group 600887 ¥31.14 ¥41.84 +34% vs BU
The Kraft Heinz Company KHC $24.24 $29.20 +20% vs BU
Foshan Haitian Flavouring and Food Company 603288 ¥35.46 ¥39.22 +11% vs BU
General Mills, Inc GIS $34.60 $35.30 +2% vs BU
Danone S.A BN €68.32 €50.65 −26% vs BU
Nestlé S.A NESN CHF 86.41 CHF 59.51 −31% vs BU
Kerry Group KRZ €97.10 €60.33 −38% vs BU
Nestlé India Limited NESTLEIND ₹1,298 ₹724.74 −44% vs BU
Yihai Kerry Arawana Holdings 300999 ¥25.92 ¥12.21 −53% vs BU

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Burcon NutraScience Corporation: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Burcon NutraScience Corporation Fair Value". https://www.fairvalue-calculator.com/stock/BU

Frequently asked questions

Is Burcon NutraScience Corporation (BU) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is C$0.6216 versus a price of C$0.9500, about 35% lower (overvalued).
What is the fair value of BU?
Our estimate for Burcon NutraScience Corporation is C$0.6216 (as of Nov 10, 2026), built from audited fundamentals. The current price: C$0.9500.
What is the quality score of BU?
Burcon NutraScience Corporation has a Quality Score of 20/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Burcon NutraScience Corporation (BU)?
Our calculated price target is the estimate of C$0.6216 (as of Nov 10, 2026). Cautious scenario C$0.4662, optimistic scenario C$0.7770. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Burcon NutraScience Corporation stock forecast for 2026?
Our estimate puts fair value at C$0.6216, about 35% lower versus a price of C$0.9500 (overvalued). Cautious scenario C$0.4662, optimistic scenario C$0.7770. The calculation is refreshed regularly with new filings.
What is the revenue of Burcon NutraScience Corporation (BU)?
Burcon NutraScience Corporation reported trailing-twelve-month revenue of about C$3.2M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Burcon NutraScience Corporation (BU)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Burcon NutraScience Corporation it is C$0.6216 per share (as of Nov 10, 2026), against a price of C$0.9500.
Is Burcon NutraScience Corporation stock overvalued or undervalued in 2026?
As of Nov 10, 2026, BU trades above its calculated fair value: price C$0.9500, fair value C$0.6216, a gap of about −35% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BU?
No. The price is what the market pays today (C$0.9500); the fair value is what the company's own numbers justify (C$0.6216). For Burcon NutraScience Corporation the two are C$0.3284 per share apart. That gap is exactly why we show both numbers side by side.
How much is Burcon NutraScience Corporation worth?
The market values Burcon NutraScience Corporation at about C$12.1M (market capitalisation, as of Nov 10, 2026). Per share that is C$0.9500; our models calculate a fair value of C$0.6216 per share.
What do the bullish and bearish scenarios say about BU?
Our models span a range for Burcon NutraScience Corporation: cautious scenario C$0.4662, base C$0.6216, optimistic C$0.7770 per share (as of Nov 10, 2026, price C$0.9500). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Burcon NutraScience Corporation (BU)?
Balance-sheet figures for Burcon NutraScience Corporation (as of Nov 10, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 20/100, which measures business quality independently of the share price.
How far is BU from its 52-week high?
Burcon NutraScience Corporation trades at C$0.9500, about 62% below its 52-week high of C$2.50 and 6% above the low of C$0.9000 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of C$0.6216 is for.
Which stocks are comparable to Burcon NutraScience Corporation?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Burcon NutraScience Corporation stock attractive at the current price?
The data as of Nov 10, 2026: price C$0.9500, calculated fair value C$0.6216 (−35%), Quality Score 20/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Burcon NutraScience Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Burcon NutraScience Corporation (BU)?
The closing price on Nov 10, 2026 was C$0.9500. Our estimate is C$0.6216, about 35% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Burcon NutraScience Corporation right now?
The price sits above even our optimistic bull case (C$0.7770). The favourable scenario is already priced in. Weak quality (20/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Burcon NutraScience Corporation

How large is the market capitalisation of Burcon NutraScience Corporation (BU)?
The market capitalisation of Burcon NutraScience Corporation is C$12.1M (≈ $8.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Burcon NutraScience Corporation (BU)?
The price-to-sales ratio of Burcon NutraScience Corporation is 3.81 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Burcon NutraScience Corporation (BU)?
Earnings per share at Burcon NutraScience Corporation are C$−1.15. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Burcon NutraScience Corporation (BU)?
The return on equity (ROE) of Burcon NutraScience Corporation is −2,489% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Burcon NutraScience Corporation (BU)?
On an EBIT basis the return on assets of Burcon NutraScience Corporation is −46.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Burcon NutraScience Corporation (BU)?
The operating margin of Burcon NutraScience Corporation is −246% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Burcon NutraScience Corporation (BU)?
Revenue at Burcon NutraScience Corporation is growing +273% versus a year earlier (3y avg +83.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Burcon NutraScience Corporation (BU) generate?
The free cash flow of Burcon NutraScience Corporation is −C$10.1M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Burcon NutraScience Corporation (BU) carry?
The net debt of Burcon NutraScience Corporation is C$23.5M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Burcon NutraScience Corporation in the live analysis

One click puts Burcon NutraScience Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.